Viridian Therapeutics, Inc.VRDNNASDAQ
Loading
Operating cash flow minus capital expenditures
Latest
$-276.89M
↓ 185% vs avg
Percentile
P0
Near historical low
Streak
5 yr
Consecutive declineContracting
Average
$-97.32M
Historical baseline
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $-276.89M | -18.9% |
| 2024 | $-232.83M | -25.8% |
| 2023 | $-185.07M | -95.6% |
| 2022 | $-94.64M | -72.3% |
| 2021 | $-54.92M | -84.2% |
| 2020 | $-29.82M | +17.5% |
| 2019 | $-36.14M | -32.4% |
| 2018 | $-27.29M | +4.0% |
| 2017 | $-28.41M | -292.8% |
| 2016 | $-7.23M | - |